- Advised a retail pharmacy chain on healthcare fraud/abuse and reimbursement implications involved in purchasing an Internet pharmacy company.
- Advised a major medical device manufacturer regarding how proposed federal privacy legislation and HIPAA provisions would affect the electronic transmission of patient identifiable health information.
- Advised pharmaceutical manufacturers and pharmacy chains on healthcare fraud and abuse compliance plans implementing security standards recommended by the OIG.
- Assisted pharmaceutical and medical device manufacturers in designing discount/rebate and other marketing programs to comply with safe harbors from fraud and abuse actions.